Questa Capital

Questa Capital is a United States-based venture capital firm focused on healthcare and related technology sectors, including biotech, health tech, medical devices, and healthcare services. Founded in 2016, it invests in growth-stage and later-stage opportunities and partners with strong management teams to build innovative market leaders and deliver improved care outcomes. The firm operates through funds that target opportunities across the United States, supporting portfolio companies with capital typically positioned for growth needs and scale.

Brian Butler

Partner

Shawn Conway JD

COO

Ryan Drant

Managing Director

Evans Grenier

Associate

Joe Huang

Vice President of Finance

Sanghamithra Kalimi

Associate

Justin Kirkpatrick

Partner

David Liu

Associate

Aabed Meer

Partner

Steph Scott

Vice President

Bradley Sloan

Managing Director

Eric Thakor

Vice President

43 past transactions

Bicycle Health

Venture Round in 2025
Founded in San Francisco in 2017, Bicycle Health is a virtual addiction medicine clinic specializing in treating opioid dependence or use disorder. The company offers accessible, confidential, and evidence-based treatment through its digital health platform, providing personalized medication management, behavioral health support, and peer assistance.

Aerin Medical

Venture Round in 2025
Aerin Medical is a health technology company that develops non-invasive therapeutic devices to improve nasal breathing. Its portfolio includes VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, along with VivAer Stylus and RhinAer Stylus, plus a compact console that delivers temperature-controlled radiofrequency energy to remodel nasal soft tissue. The technology targets the underlying causes of nasal congestion and offers alternatives to invasive surgery. The company, founded in 2011, is based in Sunnyvale, California.

Ossio

Series D in 2024
Ossio is an orthopedic fixation company focused on transforming the fixation landscape with OSSIOfiber and intelligent bone regeneration technology. Its biocomposite hardware is designed to provide strong initial fixation for screws, pins, and plates while enabling bone regrowth so the implant is incorporated and ultimately replaced by natural bone. The platform aims to offer a biologically friendly alternative to permanent metal implants, reducing inflammation and avoiding residual hardware. Founded in 2014, Ossio’s approach combines a mineral fiber-reinforced biocomposite with techniques that support tissue regeneration, supporting surgeons in orthopedic and podiatric procedures and addressing patients and payors with a potentially improved healing trajectory and reduced need for future interventions.

ACTO

Venture Round in 2024
ACTO is an AI-powered omnichannel education platform for life sciences companies. It delivers a cross-platform app that unifies mobile learning, content access, and engagement analytics, with admin tools that provide leaders a centralized view of learner activity and brand adherence. The platform also features voice-enabled search for MRL-approved content and messaging, enabling field representatives to locate critical materials quickly and consistently. By combining training materials and coaching tips, ACTO aims to improve field performance and ensure consistent messaging across the organization.

Mindset Medical

Series A in 2024
Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.

SamaCare

Series B in 2024
Founded in 2017, SamaCare streamlines healthcare processes by offering a cloud-based platform for specialty drug prior authorization, enrollment, and benefit verification. It uses AI to automate administrative tasks, improving patient care and reducing costs.

PocketHealth

Series B in 2024
Founded in Toronto in 2016, PocketHealth is a secure online platform enabling medical imaging providers to share patients' imaging records electronically. It facilitates instant access and sharing of sensitive medical images between providers and patients.

PatientFi

Venture Round in 2024
PatientFi, LLC is a financial service company based in Irvine, California, that operates a digital platform designed to provide financing options for patients seeking aesthetic medical procedures. Established in 2017, the company allows patients to apply for credit online and collaborates with medical practices across various elective healthcare segments, including plastic surgery, dermatology, and dentistry. PatientFi's platform offers personalized financing plans, enabling patients to afford treatments such as breast augmentation, mommy makeovers, and surgical facial rejuvenation. By connecting healthcare providers with financing alternatives, PatientFi aims to enhance access to health, beauty, and wellness treatments for patients.

Avive

Venture Round in 2024
Avive Solutions, Inc., established in 2017, is a medical technology company based in San Francisco, California. It specializes in the development of Automated External Defibrillators (AEDs) and accompanying software solutions. Avive's primary focus is to remove barriers and simplify the response to Sudden Cardiac Arrest (SCA), empowering anyone to effectively intervene in such emergencies. Their next-generation AED is designed to be easily accessible, user-friendly, and well-maintained, with a connected platform that facilitates data transfer to emergency services and medical professionals, enhancing post-rescue care.

Calyxo

Series D in 2023
Calyxo is an innovation-driven medical device company focused on improving care for patients with kidney stones. Founded in 2016, Calyxo develops a vacuum-assisted retrieval device designed to remove kidney stone fragments. The device enables extraction of multiple clots in a single insertion, delivering rapid stone-free outcomes and allowing clinicians to complete stone removal in a simple, intuitive procedure. The company is led by executives with a track record of commercializing paradigm-shifting solutions in urology and emphasizes a collaborative, diverse and dynamic culture.

Free Market Health

Series B in 2023
Founded in 2019 and based in Pittsburgh, PA, Free Market Health specializes in supporting payers and specialty pharmacies by simplifying complex markets. Its healthcare technology platform optimizes resources, maximizes opportunities, and prioritizes patient care.

Eximis Surgical

Venture Round in 2023
Eximis Surgical develops a laparoscopic specimen removal device that uses RF energized cutting wires within a containment bag to enable rapid extraction of large specimens through small incisions. Founded in 2014 and based in Louisville, Colorado, the company aims to integrate its device into standard surgical protocols to shorten procedure times, reduce patient discomfort, and maintain safety. The system segments specimens into narrow strips to produce clean tissue blocks for pathology, supporting minimally invasive surgery and enabling surgeons to perform complex resections with less invasiveness.

Cortica

Series D in 2023
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

DispatchHealth

Venture Round in 2022
Founded in 2013, DispatchHealth provides on-demand mobile and virtual healthcare services. It offers acute injury/illness evaluation, wound repair, splinting, medication administration, lab testing, imaging arrangement, and care coordination. Serving patients of all ages at home or work.

ACTO

Series B in 2022
ACTO is an AI-powered omnichannel education platform for life sciences companies. It delivers a cross-platform app that unifies mobile learning, content access, and engagement analytics, with admin tools that provide leaders a centralized view of learner activity and brand adherence. The platform also features voice-enabled search for MRL-approved content and messaging, enabling field representatives to locate critical materials quickly and consistently. By combining training materials and coaching tips, ACTO aims to improve field performance and ensure consistent messaging across the organization.

Calyxo

Series C in 2022
Calyxo is an innovation-driven medical device company focused on improving care for patients with kidney stones. Founded in 2016, Calyxo develops a vacuum-assisted retrieval device designed to remove kidney stone fragments. The device enables extraction of multiple clots in a single insertion, delivering rapid stone-free outcomes and allowing clinicians to complete stone removal in a simple, intuitive procedure. The company is led by executives with a track record of commercializing paradigm-shifting solutions in urology and emphasizes a collaborative, diverse and dynamic culture.

Aerin Medical

Private Equity Round in 2022
Aerin Medical is a health technology company that develops non-invasive therapeutic devices to improve nasal breathing. Its portfolio includes VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, along with VivAer Stylus and RhinAer Stylus, plus a compact console that delivers temperature-controlled radiofrequency energy to remodel nasal soft tissue. The technology targets the underlying causes of nasal congestion and offers alternatives to invasive surgery. The company, founded in 2011, is based in Sunnyvale, California.

Proximie

Series C in 2022
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.

Socially Determined

Series B in 2022
Founded in 2017, Socially Determined develops a risk intelligence platform focused on social determinants of health. Its core product, SocialScape, helps organizations understand and address social risks by providing actionable insights derived from various data sources. This solution is used by health plans, providers, life science companies, and government agencies to improve health outcomes and reduce costs.

Bicycle Health

Series B in 2022
Founded in San Francisco in 2017, Bicycle Health is a virtual addiction medicine clinic specializing in treating opioid dependence or use disorder. The company offers accessible, confidential, and evidence-based treatment through its digital health platform, providing personalized medication management, behavioral health support, and peer assistance.

PocketHealth

Series A in 2022
Founded in Toronto in 2016, PocketHealth is a secure online platform enabling medical imaging providers to share patients' imaging records electronically. It facilitates instant access and sharing of sensitive medical images between providers and patients.

Avive

Series A in 2022
Avive Solutions, Inc., established in 2017, is a medical technology company based in San Francisco, California. It specializes in the development of Automated External Defibrillators (AEDs) and accompanying software solutions. Avive's primary focus is to remove barriers and simplify the response to Sudden Cardiac Arrest (SCA), empowering anyone to effectively intervene in such emergencies. Their next-generation AED is designed to be easily accessible, user-friendly, and well-maintained, with a connected platform that facilitates data transfer to emergency services and medical professionals, enhancing post-rescue care.

VyncaCare

Series C in 2022
VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Cortica

Series C in 2021
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Bicycle Health

Series A in 2021
Founded in San Francisco in 2017, Bicycle Health is a virtual addiction medicine clinic specializing in treating opioid dependence or use disorder. The company offers accessible, confidential, and evidence-based treatment through its digital health platform, providing personalized medication management, behavioral health support, and peer assistance.

Proximie

Series B in 2021
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.

Claritas Rx

Private Equity Round in 2021
Founded in 2011, Claritas Rx specializes in automating and integrating channel, commercial, and clinical data for biopharmaceutical manufacturers. Its platform generates actionable business insights to enhance patient access and therapy duration.

DispatchHealth

Series D in 2021
Founded in 2013, DispatchHealth provides on-demand mobile and virtual healthcare services. It offers acute injury/illness evaluation, wound repair, splinting, medication administration, lab testing, imaging arrangement, and care coordination. Serving patients of all ages at home or work.

Eko Health

Series C in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

ControlRad

Series C in 2020
ControlRad is a company focused on creating advanced solutions to significantly lower the lifetime risk of radiation exposure associated with fixed and mobile C-arm procedures for both patients and healthcare professionals. The company develops radiation control devices that minimize ionizing radiation exposure during fluoroscopically guided interventional procedures. ControlRad's innovative add-on solutions utilize an eye tracker and a tablet interface, allowing for enhanced workflow without compromising image quality. By effectively reducing radiation dose while maintaining optimal image clarity in the areas critical for diagnosis, ControlRad supports radiologists in delivering high-quality imaging, ensuring safety and efficacy in medical procedures.

Aerin Medical

Venture Round in 2020
Aerin Medical is a health technology company that develops non-invasive therapeutic devices to improve nasal breathing. Its portfolio includes VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, along with VivAer Stylus and RhinAer Stylus, plus a compact console that delivers temperature-controlled radiofrequency energy to remodel nasal soft tissue. The technology targets the underlying causes of nasal congestion and offers alternatives to invasive surgery. The company, founded in 2011, is based in Sunnyvale, California.

DispatchHealth

Series C in 2020
Founded in 2013, DispatchHealth provides on-demand mobile and virtual healthcare services. It offers acute injury/illness evaluation, wound repair, splinting, medication administration, lab testing, imaging arrangement, and care coordination. Serving patients of all ages at home or work.

Eximis Surgical

Series A in 2020
Eximis Surgical develops a laparoscopic specimen removal device that uses RF energized cutting wires within a containment bag to enable rapid extraction of large specimens through small incisions. Founded in 2014 and based in Louisville, Colorado, the company aims to integrate its device into standard surgical protocols to shorten procedure times, reduce patient discomfort, and maintain safety. The system segments specimens into narrow strips to produce clean tissue blocks for pathology, supporting minimally invasive surgery and enabling surgeons to perform complex resections with less invasiveness.

Cortica

Venture Round in 2020
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

ControlRad

Series B in 2019
ControlRad is a company focused on creating advanced solutions to significantly lower the lifetime risk of radiation exposure associated with fixed and mobile C-arm procedures for both patients and healthcare professionals. The company develops radiation control devices that minimize ionizing radiation exposure during fluoroscopically guided interventional procedures. ControlRad's innovative add-on solutions utilize an eye tracker and a tablet interface, allowing for enhanced workflow without compromising image quality. By effectively reducing radiation dose while maintaining optimal image clarity in the areas critical for diagnosis, ControlRad supports radiologists in delivering high-quality imaging, ensuring safety and efficacy in medical procedures.

andros

Series B in 2019
Andros is an NCQA certified credentialing and provider data management solution that integrates software and services to enhance efficiency in the healthcare sector. The company provides its clients with significant improvements in credentialing processes, boasting a tenfold reduction in turnaround times and a fifteenfold increase in overall efficiency compared to industry norms. Andros aims to assist payers and provider organizations in mitigating compliance risks, streamlining operations, and enhancing the management of their provider networks, ultimately contributing to more effective healthcare delivery.

DispatchHealth

Series B in 2019
Founded in 2013, DispatchHealth provides on-demand mobile and virtual healthcare services. It offers acute injury/illness evaluation, wound repair, splinting, medication administration, lab testing, imaging arrangement, and care coordination. Serving patients of all ages at home or work.

Barricaid

Series E in 2019
Barricaid is a medical device company that specializes in developing therapeutic solutions for patients undergoing back surgery. Their primary product is a bone-anchored implant designed to reduce the incidence of reherniation and reoperation in patients with large annular defects. The implant works by physically blocking the annulus at the post-surgery defect, using a titanium alloy anchor component that secures the device in position within either the caudal or cranial-adjacent vertebral body. This innovative approach aims to improve outcomes for patients who are at high risk of requiring repeated surgeries due to herniation following lumbar discectomy surgery, particularly those suffering from sciatica.

Cortica

Venture Round in 2018
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Eximis Surgical

Venture Round in 2018
Eximis Surgical develops a laparoscopic specimen removal device that uses RF energized cutting wires within a containment bag to enable rapid extraction of large specimens through small incisions. Founded in 2014 and based in Louisville, Colorado, the company aims to integrate its device into standard surgical protocols to shorten procedure times, reduce patient discomfort, and maintain safety. The system segments specimens into narrow strips to produce clean tissue blocks for pathology, supporting minimally invasive surgery and enabling surgeons to perform complex resections with less invasiveness.

DispatchHealth

Venture Round in 2017
Founded in 2013, DispatchHealth provides on-demand mobile and virtual healthcare services. It offers acute injury/illness evaluation, wound repair, splinting, medication administration, lab testing, imaging arrangement, and care coordination. Serving patients of all ages at home or work.

Medrio

Venture Round in 2017
Medrio, Inc. is a medical software company specializing in web-based electronic data capture solutions for clinical research. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Pune, India, and Paris, France, Medrio offers a comprehensive platform that supports clinical trials across all phases, including outcomes research, registries, and retrospective chart reviews. Its software facilitates various processes such as study design, data collection, management reporting, and statistical analysis, allowing users to efficiently manage their clinical research projects through a user-friendly web interface. Medrio serves a diverse clientele, including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic institutions, and other research entities, with a focus on delivering faster, cost-effective solutions for complex clinical trials.

EPIX Therapeutics

Venture Round in 2017
EPIX Therapeutics, Inc. is a medical device company focused on developing innovative temperature-sensing irrigated radiofrequency ablation catheters for treating atrial fibrillation and other cardiac arrhythmias. The company utilizes its proprietary TempaSure technology, which employs microwave radiometry to provide real-time assessment of temperature within the heart, allowing physicians to accurately control lesion formation and enhance clinical outcomes. Founded in 2007 and headquartered in Santa Clara, California, EPIX Therapeutics was previously known as Advanced Cardiac Therapeutics, Inc. and rebranded in August 2018. The company has established strategic partnerships with industry leaders, including Abbott Laboratories and Hansen Medical Inc., to further advance its catheter-based systems aimed at improving the management of irregular heart rhythms. EPIX Therapeutics operates as a subsidiary of Medtronic plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.